RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family.

The receptor activator of NF-kappaB (RANK) is a member of the tumor necrosis factor (TNF) receptor family and acts to cause osteoclastgenesis through the interaction with its ligand, RANKL. We isolated RNA aptamers with high affinity to human RANK by SELEX. Sequence and mutational analysis revealed that the selected RNAs form a G-quartet conformation that is crucial for binding to RANK. When the aptamer binding to RANK was challenged by RANKL, there was no competition between the aptamer and RANKL. Instead, the formation of a ternary complex, aptamer-RANK-RANKL, was detected by a spin down assay and by BIAcore surface plasmon resonance analysis. Moreover, the selected aptamer efficiently bound to other TNF receptor family proteins, such as TRAIL-R2, CD30, NGFR as well as osteoprotegerin, a decoy receptor for RANK. These results suggest that the selected aptamer recognizes not the ligand-binding site, but rather a common structure conserved in the TNF receptor family proteins.

[1]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[2]  J W Szostak,et al.  RNA aptamers that bind flavin and nicotinamide redox cofactors. , 1995, Journal of the American Chemical Society.

[3]  M. Ultsch,et al.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. , 1999, Molecular cell.

[4]  D. Stuart,et al.  Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiation , 1999, Nature Structural Biology.

[5]  C. Nelson,et al.  Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. , 2001, The Journal of clinical investigation.

[6]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[7]  Takashi Ohtsu,et al.  RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. , 2003, RNA.

[8]  D. Thiele,et al.  Four-stranded nucleic acid structures 25 years later: from guanosine gels to telomer DNA. , 1990, Journal of biomolecular structure & dynamics.

[9]  H. Orr,et al.  RNA Targets of the Fragile X Protein , 2001, Cell.

[10]  L. Hofbauer,et al.  Receptor activator of nuclear factor‐κB ligand and osteoprotegerin , 2001 .

[11]  M. Ultsch,et al.  A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. , 2000, Biochemistry.

[12]  J. Tschopp,et al.  The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.

[13]  H. Yasuda,et al.  RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. , 1998, Biochemical and biophysical research communications.

[14]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[15]  J. Thompson,et al.  2 A crystal structure of an extracellular fragment of human CD40 ligand. , 1995, Structure.

[16]  S. Sprang,et al.  The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. , 1990, The Journal of biological chemistry.

[17]  J. Thompson,et al.  2 A crystal structure of an extracellular fragment of human CD40 ligand. , 1995, Structure.

[18]  J. SantaLucia,et al.  A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[20]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[21]  D. Cosman.  A family of ligands for the TNF receptor superfamily , 1994, Stem cells.

[22]  S. Targan,et al.  The Role of Chemokines and Chemokine Receptors in Mucosal Inflammation , 2000, Inflammatory bowel diseases.

[23]  Steven W. Martin,et al.  A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases , 2003, Cancer.

[24]  J. Feigon,et al.  Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Breaker.  DNA aptamers and DNA enzymes. , 1997, Current opinion in chemical biology.

[26]  S. Dower,et al.  Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. , 1995, Blood.

[27]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[28]  D. I. Stuart,et al.  Structure of tumour necrosis factor , 1989, Nature.

[29]  W. Sundquist,et al.  Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Gold,et al.  Aptamers as therapeutic and diagnostic agents. , 2000, Journal of biotechnology.

[31]  K. F. Chan,et al.  Signaling by the TNF receptor superfamily and T cell homeostasis. , 2000, Immunity.

[32]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[33]  R. Shafer,et al.  Lead is unusually effective in sequence-specific folding of DNA. , 2000, Journal of molecular biology.

[34]  O. Uhlenbeck.  Tetraloops and RNA folding , 1990, Nature.

[35]  B. Beutler,et al.  Unraveling function in the TNF ligand and receptor families. , 1994, Science.

[36]  P. Taylor,et al.  Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions. , 2000, Current directions in autoimmunity.

[37]  J. Szostak,et al.  In vitro selection of functional nucleic acids. , 1999, Annual review of biochemistry.

[38]  K Yokose,et al.  Interaction of ribosome recycling factor and elongation factor EF‐G with E. coli ribosomes studied by the surface plasmon resonance technique , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[39]  M. S. Lee,et al.  Crystal Structure of TRAIL-DR5 Complex Identifies a Critical Role of the Unique Frame Insertion in Conferring Recognition Specificity* , 2000, The Journal of Biological Chemistry.

[40]  S. Rees,et al.  Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. , 2002, Analytical biochemistry.

[41]  M. Famulok,et al.  RNA aptamers specifically interact with the prion protein PrP , 1997, Journal of virology.

[42]  D. Galson,et al.  The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption , 2000, Arthritis research.